cisplatin

You have access
Modulation of Tumor Cell Metabolism by Laser Photochemotherapy with Cisplatin or Zoledronic Acid In Vitro
PAUL GÜNTHER BAPTIST HEYMANN, KATHARINA SABINE ELISABETH HENKENIUS, THOMAS ZIEBART, ANDREAS BRAUN, KLARA HIRTHAMMER, FRANK HALLING, ANDREAS NEFF and ROBERT MANDIC

Anticancer Research March 2018, 38 (3) 1291-1301;
You have access
Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells
MARTA MICHALSKA, SUSANNE SCHULTZE-SEEMANN, IRINA KUCKUCK, ARNDT KATZENWADEL and PHILIPP WOLF

Anticancer Research March 2018, 38 (3) 1369-1375;
You have access
Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy
YASUYOSHI MIYATA, TOMOHIRO MATSUO, YUICHIRO NAKAMURA, TAKUJI YASUDA, KOJIRO OHBA, KOSUKE TAKEHARA and HIDEKI SAKAI

Anticancer Research March 2018, 38 (3) 1629-1635;
You have access
Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma
HIROTAKA KONISHI, HITOSHI FUJIWARA, ATSUSHI SHIOZAKI, KATSUTOSHI SHODA, TOSHIYUKI KOSUGA, TAKESHI KUBOTA, KAZUMA OKAMOTO and EIGO OTSUJI

Anticancer Research February 2018, 38 (2) 1017-1023;
You have access
Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy
HIRONORI FUJII, HIROTOSHI IIHARA, NORIKO KAJIKAWA, RYO KOBAYASHI, AKIO SUZUKI, YOSHIHIRO TANAKA, KAZUYA YAMAGUCHI, KAZUHIRO YOSHIDA and YOSHINORI ITOH

Anticancer Research December 2017, 37 (12) 6831-6837;
You have access
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility
GIOVANNI SCHINZARI, SANTA MONTERISI, FRANCESCO PIERCONTI, GIULIA NAZZICONE, LAURA MARANDINO, ARMANDO ORLANDI, MARCO RACIOPPI, ALESSANDRA CASSANO, PIERFRANCESCO BASSI, CARLO BARONE and ERNESTO ROSSI

Anticancer Research November 2017, 37 (11) 6453-6458;
You have access
Cisplatin-loaded, Sialyl Lewis X-Modified Liposomes: Drug Release, Biodistribution and Antitumor Efficacy
SHUICHI KISHIMOTO, NOBUHITO FUJITANI, TAKANORI OHNISHI, HIROKI AOKI, RYOSUKE SUZUKI and SHOJI FUKUSHIMA

Anticancer Research November 2017, 37 (11) 6055-6061;
You have access
Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin
SHUICHI KISHIMOTO, MEGUMI YASUDA and SHOJI FUKUSHIMA

Anticancer Research October 2017, 37 (10) 5477-5484;
You have access
Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer
KEWEN HE, XINZHAO WANG, XIYUN GUAN, QIAN YU, QINGHUA MA, ZHAOYUN LIU and ZHIYONG YU

Anticancer Research October 2017, 37 (10) 5647-5653;
You have access
Response of OVCAR-3 Cells to Cisplatin and Hyperthermia: Does Hyperthermia Really Matter?
ARTURAS SUKOVAS, VAIDOTAS CESNA, ALDONA JASUKAITIENE, GIEDRIUS BARAUSKAS, RUTA JOLANTA NADISAUSKIENE, ZILVINAS DAMBRAUSKAS, SAULIUS PASKAUSKAS and ANTANAS GULBINAS

Anticancer Research September 2017, 37 (9) 5011-5018;

Main menu

User menu

Search

cisplatin

Pages